Simultaneous analysis of mRNA and protein expression levels of ERβ1, β2, and β5 across various BC subtypes revealed that ERβ isoform expression is significantly associated with Ki67 positivity (>15%), poor prognostic markers, and reduced OS. Here, ESR2 is linked to breast cancer.